Marcelo Berlim is mainly interested in the study and treatment of depressive disorders with the use of state-of-the-art neuromodulation techniques.

Antoine Adamantidis, PhD, is interested in the underlying neural mechanism for wakefulness or vigilance states.

Ng Ying Kin uses neurochemical analyses to identify peripheral biological markers for various psychiatric disorders.

Joseph Rochford examines how antidepressants change behavioral and biological mechanisms involved in coping with stress.

Norbert Schmitz is involved in biostatistics, psychiatric epidemiology and psychometrics.  

The research of Myra Piat focuses on housing for persons with serious mental illness and recovery from serious mental illness.

Natalie Grizenko is medical director with the mandate of integrating research, teaching and clinical excellence throughout the program.

Ridha Joober developed a pharmaco-genetic profile of schizophrenia that may lead to earlier diagnosis and more effective treatment.

Jacques Tremblay is actively involved in quality assurance, and in improving the safety of medication use.

Jean Caron's research relates mainly to the epidemiology of mental illnesses and suicide.